Document Detail

Lipid nanoparticles protect from edelfosine toxicity in vivo.
MedLine Citation:
PMID:  25091376     Owner:  NLM     Status:  Publisher    
Edelfosine, an alkyl-lysophospholipid antitumor drug with severe side-effects, has previously been encapsulated into lipid nanoparticles (LN) with the purpose of improving their toxicity profile. LN are made of lipids recognized as safe by the Food and Drug Administration (FDA) and, therefore, these systems are generally considered as nontoxic vehicles. However, toxicity studies regarding the use of LN as vehicles for drug administration are limited. In the present study we investigated the in vivo toxicity of free edelfosine, and the protection conferred by LN. The free drug, non-loaded LN and edelfosine -loaded LN were orally administered to mice. Our results show that the oral administration of the free drug at 4 times higher than the therapeutic dose caused the death of the animals within 72hours. Moreover, histopathology revealed gastrointestinal toxicity and an immunosuppressive effect. In contrast, LN showed a protective effect against edelfosine toxicity even at the higher dose and were completely safe. LN are, therefore, a safe vehicle for the administration of edelfosine by the oral route. The nanosystems developed could be further used for the administration of other drugs.
Beatriz Lasa-Saracíbar; María Ángela Aznar; Hugo Lana; Ismael Aizpún; Ana Gloria Gil; Maria J Blanco-Prieto
Related Documents :
16541246 - The effect of stress on absorption of acetaminophen.
12135816 - Thiopurine s-methyltransferase activity in japanese subjects: metabolic activity of 6-m...
25456826 - Viewpoint: challenges in our understanding of neuroleptic induced parkinsonism.
19362316 - Comparison of qtinno, a fully automated electrocardiographic analysis program, to semia...
2893726 - Approach to rhinitis.
8731396 - Effect of methylprednisolone and mechanical loading on canine articular cartilage in ex...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-8-1
Journal Detail:
Title:  International journal of pharmaceutics     Volume:  -     ISSN:  1873-3476     ISO Abbreviation:  Int J Pharm     Publication Date:  2014 Aug 
Date Detail:
Created Date:  2014-8-5     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7804127     Medline TA:  Int J Pharm     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2014. Published by Elsevier B.V.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Formulation of diclofenac for dermal delivery.
Next Document:  Research advances in animal distant hybridization.